MCM
BMRA icon

Maple Capital Management’s Biomerica BMRA Stock Holding History

Maple Capital Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,875
Closed -$48K – 98
2022
Q3 		$48K Buy
+1,875
New +$48.6K 0.01% 95

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $244M AUM
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Maple Capital Management's BMRA Position: Q4 2022 in Review

Maple Capital Management sold out of Biomerica (BMRA) in Q4 2022, closing a stake of 1,875 shares — an estimated $48K sold.

Maple Capital Management first reported a position in BMRA in Q3 2022 and held it in 1 quarter. The position peaked at $48K in Q3 2022. 30 funds tracked by Wall St. Rank hold BMRA as of Q4 2022.

  • Maple Capital Management reported no remaining Biomerica position as of Q4 2022 after selling out during the quarter.
  • Maple Capital Management sold 1,875 Biomerica shares in Q4 2022, an estimated $48K.
  • Maple Capital Management first reported a position in Biomerica in Q3 2022 and held it in 1 quarter.
  • Maple Capital Management's Biomerica position peaked at $48K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Biomerica as of Q4 2022.

Based on Maple Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.